LF Brevinin, LFB

General Information


DRACP ID  DRACP03847

Peptide Name   LF Brevinin, LFB

Sequence  GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC

Sequence Length  33

UniProt ID  Not available

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C145H252N40O42S2

Absent amino acids  AEHMPRTWY

Common amino acids  G

Mass  386294

Pl  10.23

Basic residues  5

Acidic residues  1

Hydrophobic residues  12

Net charge  4

Boman Index  -41

Hydrophobicity  49.39

Aliphatic Index  114.85

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  125

Absorbance 280nm  3.91

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31234333

Title  LFB: A Novel Antimicrobial Brevinin-Like Peptide from the Skin Secretion of the Fujian Large Headed Frog, Limnonectes fujianensi

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13623

DRACP is developed by Dr.Zheng's team.